TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Moderna finds Omicron-targeting vaccine effective, eyes fall rollout

According to the data, a booster dose of the latest vaccine increased Omicron-fighting antibodies approximately eight-fold, one month after its administration, when compared to the original version.

Kyodo News
Washington, United States
Thu, June 9, 2022 Published on Jun. 9, 2022 Published on 2022-06-09T11:22:18+07:00

Change text size

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Moderna finds Omicron-targeting vaccine effective, eyes fall rollout A vial of the Moderna COVID-19 vaccine is seen at a clinic in Aschaffenburg, Germany on Jan. 15, 2021. (Reuters/Kai Pfaffenbach/File Photo)

U

S biotechnology firm Moderna said Wednesday new clinical data on an experimental coronavirus vaccine showed effectiveness against the Omicron variant, making it the company's lead candidate for distribution as a fall booster shot.

According to the data, a booster dose of the latest vaccine increased Omicron-fighting antibodies approximately eight-fold, one month after its administration, when compared to the original version.

"We anticipate more durable protection against variants of concern," Moderna CEO Stephane Bancel said in a press release, noting the company will be submitting the preliminary data and analysis on the COVID-19 booster candidate to regulators with the hope it will be available in late summer.

The so-called "bivalent booster" is meant to work against both the original strain of the novel coronavirus and the Omicron variant, which is now dominant in the United States.

The study enrolled more than 800 people who have already received three shots, with 377 administered a fourth dose of the original vaccine and 437 the new version, the company said.

The safety and the side effects were consistent with the prior booster dose of the original vaccine, it said.

 

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.

Share options

Quickly share this news with your network—keep everyone informed with just a single click!

Change text size options

Customize your reading experience by adjusting the text size to small, medium, or large—find what’s most comfortable for you.

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!

Continue in the app

Get the best experience—faster access, exclusive features, and a seamless way to stay updated.